Decoy and Quantori to Launch Google Cloud AI Platform Boosting Throughput 25–100x
Decoy Therapeutics has partnered with Quantori and secured Google Cloud funding to build a cloud-native AI-driven peptide design platform. The integrated system leveraging advanced protein folding models and GPU-accelerated molecular simulations is projected to boost Decoy’s computational throughput by 25- to 100-fold.
1. Strategic Partnership
Decoy Therapeutics has entered a strategic collaboration with Quantori, backed by Google Cloud funding, to deploy a next-generation, cloud-native platform for AI-driven peptide design. The agreement aligns Quantori’s digital engineering expertise with Decoy’s IMP3ACT™ engine to accelerate design-build-test-learn cycles in antiviral development.
2. Cloud-Native AI Platform
The platform will run on Google Cloud Platform, integrating advanced protein folding models, diffusion-based conformational sampling, molecular dynamics simulations with GPU acceleration, and automated algorithm selection. Quantori’s containerized Q-Suite accelerators will streamline AI model deployment and high-performance computing workflows within a unified production-grade environment.
3. Discovery Acceleration Impact
By unifying these capabilities, Decoy expects a 25- to 100-fold increase in computational throughput, enabling rapid iteration on peptide candidates and faster transition to structural validation. The modular architecture also supports ongoing integration of emerging generative AI techniques and proprietary structure-function data to maintain competitive advantage.